188 related articles for article (PubMed ID: 1995893)
1. Muscarinic cholinergic agonists and antagonists of the 3-(3-alkyl-1,2,4-oxadiazol-5-yl)-1,2,5,6-tetrahydropyridine type. Synthesis and structure-activity relationships.
Sauerberg P; Kindtler JW; Nielsen L; Sheardown MJ; Honoré T
J Med Chem; 1991 Feb; 34(2):687-92. PubMed ID: 1995893
[TBL] [Abstract][Full Text] [Related]
2. Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridines .
Sauerberg P; Olesen PH; Nielsen S; Treppendahl S; Sheardown MJ; Honoré T; Mitch CH; Ward JS; Pike AJ; Bymaster FP
J Med Chem; 1992 Jun; 35(12):2274-83. PubMed ID: 1613751
[TBL] [Abstract][Full Text] [Related]
3. Beta-lactam analogues of oxotremorine. 3- and 4-methyl-substituted 2-azetidinones.
Nilsson BM; Ringdahl B; Hacksell U
J Med Chem; 1990 Feb; 33(2):580-4. PubMed ID: 2299626
[TBL] [Abstract][Full Text] [Related]
4. Urea and 2-imidazolidone derivatives of the muscarinic agents oxotremorine and N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.
Nilsson BM; Vargas HM; Hacksell U
J Med Chem; 1992 Aug; 35(17):3270-9. PubMed ID: 1507212
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and neurochemical evaluation of 5-(3-alkyl-1,2,4- oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists.
Dunbar PG; Durant GJ; Fang Z; Abuh YF; el-Assadi AA; Ngur DO; Periyasamy S; Hoss WP; Messer WS
J Med Chem; 1993 Apr; 36(7):842-7. PubMed ID: 8464038
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic activity in the isolated guinea pig ileum of some carboxamides related to oxotremorine.
Ringdahl B; Resul B; Jenden DJ; Dahlbom R
Eur J Pharmacol; 1982 Nov; 85(1):79-83. PubMed ID: 7151864
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 2-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo [3.2.1]octanes and 2 alpha-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8- azabicyclo[3.2.1]oct-2-enes as potential muscarinic agonists.
Triggle DJ; Kwon YW; Abraham P; Rahman MA; Carroll FI
Pharm Res; 1992 Nov; 9(11):1474-9. PubMed ID: 1475236
[TBL] [Abstract][Full Text] [Related]
8. The pharmacological assessment of RS 86 (2-ethyl-8-methyl-2,8-diazaspiro-[4,5]-decan-1,3-dion hydrobromide). A potent, specific muscarinic acetylcholine receptor agonist.
Palacios JM; Bolliger G; Closse A; Enz A; Gmelin G; Malanowski J
Eur J Pharmacol; 1986 Jun; 125(1):45-62. PubMed ID: 3732391
[TBL] [Abstract][Full Text] [Related]
9. Stereochemical requirements for central and peripheral muscarinic and antimuscarinic activity of some acetylenic compounds related to oxotremorine.
Dahlbom R; Jenden DJ; Resul B; Ringdahl B
Br J Pharmacol; 1982 Jun; 76(2):299-304. PubMed ID: 7093587
[TBL] [Abstract][Full Text] [Related]
10. Phenyl-substituted analogues of oxotremorine as muscarinic antagonists.
Nilsson BM; Vargas HM; Ringdahl B; Hacksell U
J Med Chem; 1992 Jan; 35(2):285-94. PubMed ID: 1732545
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 1-methyl-5-(pyrazol-3- and -5-yl- and 1, 2, 4-triazol-3- and 5-yl)-1, 2, 3, 6-tetrahydropyridine derivatives and their evaluation as muscarinic receptor ligands.
Del Giudice MR; Mustazza C; Borioni A; Gatta F; Tayebati K; Amenta F; Tucci P; Pieretti S
Arch Pharm (Weinheim); 2003 Jun; 336(3):143-54. PubMed ID: 12822179
[TBL] [Abstract][Full Text] [Related]
12. Novel functional M1 selective muscarinic agonists. 2. Synthesis and structure-activity relationships of 3-pyrazinyl-1,2,5,6-tetrahydro-1-methylpyridines. Construction of a molecular model for the M1 pharmacophore.
Ward JS; Merritt L; Klimkowski VJ; Lamb ML; Mitch CH; Bymaster FP; Sawyer B; Shannon HE; Olesen PH; Honoré T
J Med Chem; 1992 Oct; 35(22):4011-9. PubMed ID: 1433209
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, molecular modeling studies, and muscarinic receptor activity of azaprophen analogues.
Triggle DJ; Kwon YW; Abraham P; Pitner JB; Mascarella SW; Carroll FI
J Med Chem; 1991 Nov; 34(11):3164-71. PubMed ID: 1956033
[TBL] [Abstract][Full Text] [Related]
14. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
Shannon HE; Bymaster FP; Calligaro DO; Greenwood B; Mitch CH; Sawyer BD; Ward JS; Wong DT; Olesen PH; Sheardown MJ; Swedberg MD; Suzdak PD; Sauerberg P
J Pharmacol Exp Ther; 1994 Apr; 269(1):271-81. PubMed ID: 7909557
[TBL] [Abstract][Full Text] [Related]
15. Alkylating partial muscarinic agonists related to oxotremorine. N-[4-[(2-haloethyl)methylamino]-2-butynyl]-5-methyl-2-pyrrolidones.
Ringdahl B; Roch M; Katz ED; Frankland MC
J Med Chem; 1989 Mar; 32(3):659-63. PubMed ID: 2918515
[TBL] [Abstract][Full Text] [Related]
16. Derivatives of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.
Nilsson BM; Ringdahl B; Hacksell U
J Med Chem; 1988 Mar; 31(3):577-82. PubMed ID: 3346873
[TBL] [Abstract][Full Text] [Related]
17. Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: evidence for involvement of different muscarinic receptor subtypes.
Arnt J; Lembøl HL; Meier E; Pedersen H
Eur J Pharmacol; 1992 Jul; 218(1):159-69. PubMed ID: 1397027
[TBL] [Abstract][Full Text] [Related]
18. Quest for agonist and antagonist selectivity at muscarinic receptors in guinea-pig smooth muscles and cardiac atria.
Dorofeeva NA; Shelkovnikov SA; Starshinova LA; Danilov AF; Nedoma J; Tucek S
Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):383-90. PubMed ID: 1436123
[TBL] [Abstract][Full Text] [Related]
19. [Structure-activity relationship in the series of muscarinic acetylcholine receptor agonists: three types of agonist-receptor complexes].
Tropsha AE; Nizhniĭ SV; Iaguzhinskiĭ LS
Bioorg Khim; 1985 Oct; 11(10):1391-401. PubMed ID: 4074399
[TBL] [Abstract][Full Text] [Related]
20. 5-Methyl-2-pyrrolidone analogues of oxotremorine as selective muscarinic agonists.
Ringdahl B
J Med Chem; 1988 Mar; 31(3):683-8. PubMed ID: 3346881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
